BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8959343)

  • 1. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter.
    Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS
    Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of sequence-specific binding activity of cis-elements in human thymidine kinase gene promoter during G1/S phase transition.
    Good L; Chen J; Chen KY
    J Cell Physiol; 1995 Jun; 163(3):636-44. PubMed ID: 7775606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features.
    Lee Y; Johnson LF
    Exp Cell Res; 2000 Jul; 258(1):53-64. PubMed ID: 10912787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation.
    Li LJ; Naeve GS; Lee AS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3554-8. PubMed ID: 8475104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-Y-mediated trans-activation of the human thymidine kinase promoter is closely linked to activation of cyclin-dependent kinase.
    Chang ZF; Huang DY; Hu SF
    J Cell Biochem; 1999 Nov; 75(2):300-9. PubMed ID: 10502302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
    Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
    Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B; Stein JL; van Wijnen AJ; Stein GS
    Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F and GATA-1 are required for the Sertoli cell-specific promoter activity of the follicle-stimulating hormone receptor gene.
    Kim JS; Griswold MD
    J Androl; 2001; 22(4):629-39. PubMed ID: 11451360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
    Cartwright P; Müller H; Wagener C; Holm K; Helin K
    Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
    EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element.
    Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C
    Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.